Disclosed herein are embodiments of a combination and/or composition for administration to animals. In some embodiments, the combination and/or composition can be administered to treat and/or prevent a disease in animals. In some embodiments, the combination and/or composition can be administered to promote animal health. In some embodiments, the combination comprises a composition comprising Yucca schidigera, Quillaja saponaria, and combinations thereof and a composition comprising an antimicrobial, an antibiotic, an anticoccidial, a vaccine, or combinations thereof. The combinations or compositions disclosed herein can also improve feed conversion rates in animals.

Disclosed herein are embodiments of a combination and/or composition for administration to animals. In some embodiments, the combination and/or composition can be administered to treat and/or prevent a disease in animals. In some embodiments, the combination and/or composition can be administered to promote animal health. In some embodiments, the combination comprises a composition comprising Yucca schidigera, Quillaja saponaria, and combinations thereof and a composition comprising an antimicrobial, an antibiotic, an anticoccidial, a vaccine, or combinations thereof. The combinations or compositions disclosed herein can also improve feed conversion rates in animals.

The present invention relates to a novel bacteriophage CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage CJ24 (KCCM11462P) or the composition.

The present invention relates to a novel bacteriophage CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage CJ24 (KCCM11462P) or the composition.

Hormesis model (i.e. a toxicant excitation effect or a low dose promoting effect) is firstly used to study the relationship between the amount and efficacy of tea seed meal in feed industry. The amount of the tea seed meal as feed additive for the low dose promoting effect is determined to be 0.25-4 kg per ton of complete feed in the monogastric animal feed. The use method and the amount of the tea seed meal as feed additive can improve animal growth performance, such as increase daily weight gain, improve feed conversion ratio and decrease mortality.

It has been found that administering probiotic Bacillus strains to animals improves vitamin E absorption. Thus, probiotic Bacillus strains can be used when animals are stressed, e.g. during weaning. The present invention relates to a Bacillus strain as a feed additive, which is useful for improving vitamin E absorption in animals.

A wild bird feed product is made by cold co-extrusion so as to produce a soft inner core encapsulated in a hard outer shell. Both the core and shell are made of edible ingredients and formulated so as to attract a variety of birds. The shell provides structural strength for the soft inner core and provides weather resistance for the feed product, while the high-fat content inner core remains soft, even in cold-weather environments. The feed product provides necessary nutrition for the birds, including fat, sugar, protein, and other supplements.

A wild bird feed product is made by cold co-extrusion so as to produce a soft inner core encapsulated in a hard outer shell. Both the core and shell are made of edible ingredients and formulated so as to attract a variety of birds. The shell provides structural strength for the soft inner core and provides weather resistance for the feed product, while the high-fat content inner core remains soft, even in cold-weather environments. The feed product provides necessary nutrition for the birds, including fat, sugar, protein, and other supplements.

The present application relates to the treatment of nematode infections. For example, the application relates to the use of compounds of Formula (I) and/or (II) as defined herein for treatment of a nematode infection or a disease, disorder or condition arising from a nematode infection:

##STR00001##

Embodiments of a composition comprising three or four Bacillus species selected from Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus licheniformis and Bacillus coagulans are disclosed. The composition may further comprise, or be used in combination with, feed and/or feed supplements, including feed supplements comprising yucca, quillaja, silica, mineral clay, glucan, mannans, or combinations thereof. Also disclosed is a method of administering the composition and/or combination to animals, such as poultry.